Vaxcyte, Inc.
PCVX
$31.16
-$0.29-0.92%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.67B | 1.75B | 2.18B | 1.45B | 1.49B |
Total Receivables | -- | 20.66M | 17.87M | 17.88M | 8.15M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 44.83M | 15.73M | 10.59M | 9.18M | 7.77M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 4.38M | 4.94M | 1.72M | 14.64M |
Total Current Assets | 1.72B | 1.79B | 2.21B | 1.48B | 1.52B |
|
|||||
Total Current Assets | 1.72B | 1.79B | 2.21B | 1.48B | 1.52B |
Net Property, Plant & Equipment | 304.91M | 270.15M | 191.94M | 152.75M | 113.74M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 77.60M | 65.68M | 61.36M | 53.79M | 47.25M |
Total Assets | 3.38B | 3.51B | 3.56B | 2.09B | 2.09B |
|
|||||
Total Accounts Payable | 20.51M | 48.45M | 18.22M | 10.47M | 21.72M |
Total Accrued Expenses | 70.35M | 85.84M | 95.93M | 65.09M | 58.19M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.13M | 5.89M | 9.64M | 7.29M | 7.20M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 97.00M | 140.18M | 123.79M | 82.85M | 87.10M |
|
|||||
Total Current Liabilities | 97.00M | 140.18M | 123.79M | 82.85M | 87.10M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 81.08M | 65.22M | 18.32M | 18.29M | 20.22M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 100.00K | -- | -- | -- |
Total Liabilities | 178.08M | 205.50M | 142.11M | 101.14M | 107.32M |
|
|||||
Common Stock & APIC | 4.73B | 4.70B | 4.67B | 3.13B | 3.00B |
Retained Earnings | -1.53B | -1.39B | -1.25B | -1.15B | -1.02B |
Treasury Stock & Other | -322.00K | -3.87M | 139.00K | 1.82M | 2.89M |
Total Common Equity | 3.20B | 3.31B | 3.42B | 1.99B | 1.98B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.20B | 3.31B | 3.42B | 1.99B | 1.98B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.20B | 3.31B | 3.42B | 1.99B | 1.98B |
|